Vudalimab

(Synonyms: XmAb20717)
Avis client

Based on 1 Customer Validation

Vudalimab (XmAb20717) is a bispecific antibody that binds PD-1 and CTLA-4. Vudalimab preferentially binds to cells co-expressing PD-1 and CTLA-4 and blocks inhibitory checkpoint signaling to promote T cell activation. Vudalimab can be used for research in metastatic castration-resistant prostate cancer (including high-risk disease) and gynecological malignancies.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté : ≥99.0%
  • CAS No.: 2329669-72-7
  • Masse moléculaire:144.5 kDa
  • Stockage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00